Life Science Compliance Update



FDA’s Meeting on Promotion – Can We Glimpse the Future?

Written by , Posted in Free speech

Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update

In November, the FDA held a two-day Town Hall meeting to allow for input from stakeholders and patients surrounding agency regulation of manufacturer communications regarding unapproved uses of drugs and medical devices. This article provides a brief summary of the two-day event, including several presenters and their opinions.


Topic tags:

Gravityscan Badge
Menu Title